Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
Despite extensive technological advances in recent years, objective and continuous assessment of physiologic measures after vaccination is rarely performed. We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pf...
Main Authors: | Merav Mofaz, Matan Yechezkel, Grace Guan, Margaret L. Brandeau, Tal Patalon, Sivan Gazit, Dan Yamin, Erez Shmueli |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2022-07-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/28/7/21-2330_article |
Similar Items
-
Effectiveness of mRNA BNT162b2 Vaccine 6 Months after Vaccination among Patients in Large Health Maintenance Organization, Israel
by: Jennifer Kertes, et al.
Published: (2022-02-01) -
Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
by: Mineaki Kitamura, et al.
Published: (2022-04-01) -
Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel
by: Aharona Glatman-Freedman, et al.
Published: (2022-05-01) -
Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine
by: Marcela Helena Gambim Fonseca, et al.
Published: (2022-06-01) -
Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine
by: Yftach Gepner, et al.
Published: (2022-03-01)